Effects of burosumab treatment on mineral homeostasis in children and adolescents with X-linked hypophosphatemia: lessons from the German XLH Registry

被引：0
|
作者：
Ewert, Annika [1 ]
Rehberg, Mirko [2 ]
Schlingmann, Karl Peter [3 ]
Kemper, Markus [4 ]
Patzer, Ludwig [5 ]
John, Ulrike [6 ]
Metzing, Oliver [6 ]
Staude, Hagen [7 ]
Weitz, Marcus [8 ]
Wuehl, Elke [9 ,10 ]
Schaefer, Franz [9 ,10 ]
Freiberg, Clemens [11 ]
Hiort, Olaf [12 ]
Schnabel, Dirk [13 ]
Haffner, Dieter [1 ]
机构：
[1] Hannover Med Sch, Dept Pediat Nephrol, Hannover, Germany
[2] Univ Cologne, Dept Pediat, Cologne, Germany
[3] Univ Childrens Hosp, Dept Gen Pediat Pediat Nephrol, Munster, Germany
[4] Asklepios Childrens Hosp Hamburg Heidberg, Pediat, Hamburg, Germany
[5] St Elisabeth & St Barbara Childrens Hosp, Pediat, Halle, Germany
[6] Univ Childrens Hosp, Pediat Nephrol, Jena, Germany
[7] Univ Childrens Hosp, Pediat Nephrol, Rostock, Germany
[8] Univ Childrens Hosp, Pediat Nephrol, Tubingen, Germany
[9] Univ Heidelberg Hosp, Div Pediat Nephrol, Heidelberg, Germany
[10] Ctr Pediat & Adolescent Med, Heidelberg, Germany
[11] Univ Med Gottingen, Dept Pediat, Gottingen, Germany
[12] Univ Childrens Hosp Lubeck, Pediat, Lubeck, Germany
[13] Univ Med Charite, Ctr Chronically Sick Children Pediat Endocrinol, Berlin, Germany
来源：
PEDIATRIC NEPHROLOGY | 2023年 / 38卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
O-19
引用
收藏
页码：2264 / 2265
页数：2
相关论文
共 50 条
  • [21] Sustained Efficacy and Safety of Burosumab, an Anti-FGF23 Monoclonal Antibody, for 88 Weeks in Children and Early Adolescents with X-Linked Hypophosphatemia (XLH)
    Carpenter, Thomas O.
    Hogler, Wolfgang
    Imel, Erik
    Portale, Anthony A.
    Boot, Annemieke
    Linglart, Agnes
    Padidela, Raja
    Van'T Hoff, William
    Gottesman, Gary S.
    Mao, Meng
    Skrinar, Alison
    San Martin, Javier
    Whyte, Michael P.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 120 - 120
  • [22] Body composition and cardiometabolic health of pediatric patients with X-linked hypophosphatemia (XLH) under burosumab therapy
    Brener, Avivit
    Lebenthal, Yael
    Cleper, Roxana
    Kapusta, Livia
    Zeitlin, Leonid
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2021, 12
  • [23] COMPREHENSIVE APPROACH TO THE MANAGEMENT AND TREATMENT OF ADULTS WITH X-LINKED HYPOPHOSPHATEMIA (XLH)
    Polonsky, A. C.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S111 - S113
  • [24] Three-Year Safety and Efficacy Results of Burosumab for Children Aged 1 to 4 years with X-linked Hypophosphatemia (XLH)
    Imel, Erik
    Carpenter, Thomas
    Gottesman, Gary
    Chen, Angel
    Skrinar, Alison
    Roberts, Mary Scott
    Whyte, Michael P.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 : 16 - 16
  • [25] Burosumab for X-linked hypophosphatemia in children and adolescents: Opinion based on early experience in seven European countries
    Mughal, M. Zulf
    Baroncelli, Giampiero I.
    de Lucas-Collantes, Carmen
    Linglart, Agnes
    Magnolato, Andrea
    Raimann, Adalbert
    Santos, Fernando
    Schnabel, Dirk
    Shaw, Nick
    Nilsson, Ola
    FRONTIERS IN ENDOCRINOLOGY, 2023, 13
  • [26] Meta-analysis and systematic review: burosumab as a promising treatment for children with X-linked hypophosphatemia
    Wang, Kangning
    Zhang, Runze
    Chen, Ziyi
    Bai, Yi
    He, Qing
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [27] Hyperparathyroidism after three years of burosumab in children affected with x-linked hypophosphatemia
    Zhukouskaya, Volha V.
    Ertl, Diana-Alexandra
    Berkenou, Jugurtha
    Audrain, Christelle
    Bardet, Claire
    Rothenbuhler, Anya
    Linglart, Agnes
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 : 33 - 33
  • [28] Growth pattern in children with X-linked hypophosphatemia treated with burosumab and growth hormone
    Ertl, Diana-Alexandra
    Le Lorier, Justin
    Gleiss, Andreas
    Trabado, Severine
    Bensignor, Candace
    Audrain, Christelle
    Zhukouskaya, Volha
    Coutant, Regis
    Berkenou, Jugurtha
    Rothenbuhler, Anya
    Haeusler, Gabriele
    Linglart, Agnes
    ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
  • [29] Elevated blood pressure in pediatric patients with X-linked hypophosphatemia is associated with BMI and treatment modality: An analysis of the German/Swiss XLH Registry
    Boeckmann, Ineke
    Leifheit-Nestler, Maren
    John, Ulrike
    Metzing, Oliver
    Rehberg, Mirko
    Schlingmann, Karl
    Kemper, Markus
    Patzer, Ludwig
    Weitz, Marcus
    Wuehl, Elke
    Freiberg, Clemens
    Sparta, Guiseppina
    Hoppe, Bernd
    Schnabel, Dirk
    Haffner, Dieter
    PEDIATRIC NEPHROLOGY, 2024, 39 (01) : S263 - S264
  • [30] Growth pattern in children with X-linked hypophosphatemia treated with burosumab and growth hormone
    Diana-Alexandra Ertl
    Justin Le Lorier
    Andreas Gleiss
    Séverine Trabado
    Candace Bensignor
    Christelle Audrain
    Volha Zhukouskaya
    Régis Coutant
    Jugurtha Berkenou
    Anya Rothenbuhler
    Gabriele Haeusler
    Agnès Linglart
    Orphanet Journal of Rare Diseases, 17
12345